DrugSpace Symposium Spring 2023

Connect the Dots for Future Drug Discovery

In our third virtual BioSolveIT DrugSpace Symposium, focus is placed on the recent trends that transform modern drug discovery: machine learning, artificial intelligence, neural networks, and processing big data.
Can recent developments live up to the hype around AI, or is there still a long way to go? This event brings researchers together who aim to discover future drug candidates from a myriad of data flows. An exciting journey lies ahead of us!

Medicinal chemists, decision makers, representatives of crop-, pharmaceutical-, and medicine-related businesses, undergraduates and PhD students, researchers — simply anyone interested in future technologies and state-of-the-art drug development — you are cordially invited to participate in this virtual event. Again, this BioSolveIT Symposium aims to be accessible to the entire global research community; BioSolveIT takes pride in thanking all brilliant speakers and participants for their contribution to the event in advance.

The third DrugSpace Symposium takes place on 24 and 25th May, 2023 — starting daily at 3 pm CEST/Berlin. Registration and participation is free-of-charge.

Register for free for the DrugSpace 2023 Symposium

DrugSpace 2023 Programme

Once again, we are very proud to host renowned experts in their fields from around the globe, contributing their knowledge to the scientific community.

Follow Us on Social Media

Don't want to miss the latest BioSolveIT updates on upcoming events, success stories, and software updates?
Follow us on our social media channels, and be always up-to-date with the latest developments in the drug discovery community.

Confirmed Speakers

  • Philippe Schwaller
    (École Polytechnique Fédérale de Lausanne)
    "AI-Accelerated Organic Synthesis"
  • Quentin Perron
    (Iktos)
    "Yes, You Should Use AI for Medicinal Chemistry"
  • Léa El Khoury
    (Qubit)
    "Application of Absolute Binding Free Energy Calculations to Predict the Binding Modes and Affinities of Protein-Protein Inhibitors"
  • Francesca Grisoni
    (Eindhoven University of Technology)
    "Deep Learning for Drug Discovery: Challenges and Opportunities"
  • Marcus Gastreich
    (BioSolveIT)
    "Claw Machines for Exploding Chemical Spaces"
  • Yurri Moroz
    (Chemspace)
    "Making Virtual REAL: Creation and Use of the Giga-Scale Chemical Spaces"
  • Dusan Petrovic
    (Nuvisan)
    "Virtual Screening for Multiple Modalities"
  • Connor Coley
    (Massachusetts Institute of Technology)
    "Learning to Navigate Synthetically Accessible Chemical Space"
  • Henry van den Bedem
    (Atomwise)
    "An Efficient Graph Generative Model for Navigating Ultra-Large Combinatorial Synthesis Libraries"
  • Nick Antonopoulos
    (DeepLab)
    "Scalable and High-Throughput Deep Neural Virtual Screening"
  • Lewis Martin
    (OpenBench)
    "Fast and Economical Hit Finding with Active Learning"
  • Daniel Kuhn
    (Merck)
    "You Can't Improve What You Don't Measure — Measuring ML/AI Impact in Drug Discovery Projects"
  • Christoph Grebner
    (Sanofi)
    "AI-Driven Mining of Accessible Chemical Spaces"

Latest news

category
Webinars
Advancing Efficient GPCR Drug Discovery via Computational Methods
Thu, 27 Mar 2025, 16:00 CET (Berlin)
Modern drug discovery is a long and tedious process which takes, on average, at least 10 years and 2 billion USD to bring a drug to market. One of the most critical challenges in our industry today is accelerating this costly process. With advancements in artificial intelligence and computational biology,...
Read on
CHEMriya Space Update: 55 Billion Molecules Unlocking New Frontiers in Drug Discovery!
March 13, 2025 14:00 CET
We are excited to announce a major update to OTAVA’s CHEMriya™ Chemical Space, now featuring 55 billion accessible molecules built upon 323 in-house reactions. With the March 2025 update, several new reactions have been added to the chemistry portfolio, expanding the space by over 43 billion novel molecules. This significant...
Read on
category
Webinars
Augmenting AI in Drug Discovery: How to Boost Workflow Performance (Workshop)
Thu, 27 Feb 2025, 16:00 CET
The experience of recent years has shown that a common theme emerges in the context of machine learning (ML) and artificial intelligence (AI): the more and broader data the better. To increase the precision of predictions, it is not only necessary to have more data points but also to incorporate...
Read on